Israel’s vaccine data suggests that Pfizer is performing at the expected 95%
New vaccine data from Israel suggests that the double-dose of Pfizer is performing at the expected rate of 95% efficiency - with the possibility that it is performing even better than that being further investigated.
People with high omega-3 blood levels are less likely to die from COVID-19
Researchers have found that people with higher omega-3 blood levels have a reduced risk of death from COVID-19.
Moderna vaccine works on South African COVID mutation
The company announced that their current vaccine can handle the South African COVID mutation - with plans to create an "additional booster dose" to see if they can create specific protections against emerging variants.
UK offers genomics expertise to find COVID-19 virus variants across the world
The UK will offer its world-leading genomics expertise to identify new variants of the COVID-19 virus to countries who do not have the resources to do so.
European Commission will get 60% less AstraZeneca vaccines
EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.
Studies show promising results for new Oxford COVID-19 vaccine
Studies show that the new Oxford-produced RBD-SpyVLP COVID-19 vaccine produces a strong antibody response in mice and pigs.
Asian COVID patients are 1.5 times more likely to die
Data from Queen Mary University of London suggests that Asian COVID patients are 1.5 times as likely to die as white patients - with Black patients 1.3 times more likely to die.
Scientist warns UK not to rely on one dose of COVID vaccine
Professor Herb Sewell, expert in immunology, wrote that the UK Government should not rely on one dose of the vaccine - suggesting that the diluted vaccine could encourage mutations to evolve.
REACT study: There is “extreme pressure on healthcare services”
New data from the REACT study says that there have been more than 20 hospitals' worth of new patients since Christmas Eve, putting "extreme pressure" on the NHS.
COVID-19 spike proteins could evolve against immune responses
A new study suggests that COVID-19 spike proteins could evolve to disguise themselves from the human immune system.
European Commission outlines key actions to beat COVID-19
The European Commission has set out the key actions needed to step up the fight against the COVID-19 pandemic.
2,000 supply chain workers will be offered the COVID-19 vaccine
Up to 2,000 supply chain workers who are crucial to the delivery of the COVID-19 vaccine will be offered the vaccination themselves.
Over 4 million people receive first dose of COVID-19 vaccine
More than 4 million people have now received the first dose of the COVID-19 vaccine in the UK, according to the latest statistics.
Social care sector to receive further £120 million for additional care staff
The Government has allocated a further £120 million for the social care sector to help with staff shortages due to the pandemic.
Scientists use immune system to predict likelihood of long COVID
Cambridge researchers have published their findings on how the immune system could be an early clue for the later development of severe or long COVID.
Over 70s will begin to receive COVID-19 vaccine today
People aged 70 and over and those clinically extremely vulnerable will be invited to get their COVID-19 vaccinations from today.
NHS awarded £7.5 million to digitally schedule shifts
Government allocates £7.5 million to NHS hospitals, clinics and pharmacies across 38 trusts to implement digital shift planning.
DNA testing can rapidly identify pneumonia in COVID-19 patients
Researchers have developed a DNA test to rapidly identify pneumonia in COVID-19 patients, aiding faster treatment.
More than a third of people over 80 have received the COVID-19 vaccine
New data from Public Health England (PHE) shows that more than a third of people aged 80 and over have received the COVID-19 vaccine.
The vaccine isn’t a silver bullet for longstanding pressures in elderly care
Jitesh Patel, Project Director at Kajima Partnerships discusses why the vaccine is not a silver bullet for longstanding pressures in elderly care and how the sector must adapt post-pandemic.